Triple artemisinin-based combination therapies for malaria – a new paradigm?
Recent gains in the fight against malaria are threatened by the emergence and spread of artemisinin and partner drug resistance in Plasmodium falciparum in the Greater Mekong Subregion (GMS). When artemisinins are combined with a single partner drug, all recommended artemisinin-based combination the...
Main Authors: | van der Pluijm, RW, Amaratunga, C, Dhorda, M, Dondorp, AM |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2020
|
Similar Items
-
Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations
by: Tindana, P, et al.
Published: (2021) -
Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
by: van der Pluijm, RW, et al.
Published: (2022) -
Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations
by: Paulina Tindana, et al.
Published: (2021-02-01) -
Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
by: Nguyen, TD, et al.
Published: (2023) -
Modulation of triple artemisinin-based combination therapy pharmacodynamics by Plasmodium falciparum genotype
by: Ansbro, MR, et al.
Published: (2020)